The common cold is viral infection of the upper respiratory tract, which means that the nose and throat are primarily affected. Children in preschool are at the greatest risk for catching a cold, but even perfectly healthy adults will get one or two a year. Although these infections usually clear up on their own within a week or two, some can get serious. By conducting common cold clinical trials, we can gain new insight into how future infections could be prevented. If you are experiencing the symptoms of a common cold, then you should focus on getting plenty of rest to fight off the infection.
The symptoms of the common cold can include a runny nose, dry or sore throat, coughing, and sometimes a fever. With proper symptomatic relief, a cold should start to get better within ten days, even though some symptoms may persist for a few weeks. Scientists have been able to identify more than 200 viruses which can play a role in causing a common cold, although the most common is the rhinoviruses.
An upper respiratory tract infection are separated by the zones they affect. A cold primarily affects the nose, sinuses, and throat (also the eyes on occasion through conjunctivitis). The symptoms a patient experiences is primarily the immune response to an infection, instead of the result of any tissue damage caused by the virus. In rare cases, a common cold could cause pneumonia (either viral or bacterial). One of the best ways one can protect themselves if by making sure to wash their hands regularly.
At this time, there is no cure available for the common cold, but symptoms can be treated directly. With most adults catching at least two colds every year, this is the most common form of infection experienced by human beings around the world. It is even more common amongst children with the average child contracting anywhere between six to twelve per year (remember to wash your hands). Through more research, there may come a day quite soon when infection is no longer considered “common”.
The common cold clinical trials taking place in Florida are helping to develop better treatments, which are being produced by pharmaceutical and biotechnical companies. They are designed specifically to test the safety and efficacy of experimental therapies in human patients. If you are interested in participating in our new common cold clinical study, you will be helping leading clinical investigators develop better ways to combat a common infection.
The type of study being performed by Avail Clinical Research directly reflects your involvement. Sometimes, participating in a common cold clinical trial is as simple as agreeing to let our researchers have a copy of your test results, but most are more involved and would require some tests with a visit to our clinic. Of course, participants will be compensated for time and travel, and all study related care, including physical examinations, laboratory services and study medicines are provided free of charge.
Common Cold Clinical Trials Now Enrolling in DeLand, FL
Avail Clinical Research specializes in conducting phase I clinical trials targeted towards certain conditions. You may be eligible to participate in our next common cold clinical trial and contribute to the development and approval of a new drug or treatment. As a participant, there is no cost to you at any point during the study and health insurance is not required. Browse our clinical trials being conducted now to find the study best suited for you.
Resources for the Common Cold
If you live near Central Florida, click here to learn more about participating in a common cold clinical trial.